References
Oct 26, 1991·Lancet·P L YudkinC Milanese
Jul 7, 1990·Lancet·R L Swank, B B Dugan
Feb 1, 1986·Neurology·L DurelliL Bergamini
Jan 27, 1983·The New England Journal of Medicine·S L HauserH L Weiner
Nov 1, 1984·Neurology·R H DworkinD W Paty
Jan 1, 1995·Annals of Neurology·B Weinstock-GuttmanR A Rudick
Sep 1, 1995·Journal of Neuroimmunology·R Milo, H Panitch
Jul 1, 1995·Neurology·K P JohnsonR B Schiffer
Jan 1, 1995·Annals of Neurology·D E GoodkinC Van Dyke
Dec 9, 1993·The New England Journal of Medicine·R W BeckC H Brown
May 1, 1993·Neurology·H L WeinerA Turel
Mar 1, 1996·Annals of Neurology·L D JacobsR H Whitham
Apr 1, 1996·Neurology·F D Lublin, S C Reingold
Nov 1, 1996·Neurology·D E GoodkinC Van Dyke
Mar 1, 1996·Journal of Neurology·J LyckeO Andersen
Mar 1, 1997·Lancet·F FazekasB Mamoli
Mar 29, 1997·Lancet·D BarnesJ Frankel
May 1, 1997·Neurology·P A CalabresiH F McFarland
May 22, 1998·Neurology·P S SorensenM L Lee
Jun 26, 1998·Immunology Today·P C Calder
Jul 17, 1998·Annals of Neurology·F WeberP Rieckmann
Jul 23, 1998·Neurology·D E GoodkinL Neilley
Sep 25, 1998·Neurology·V W YongG Williams
Nov 6, 1998·Journal of the Neurological Sciences·P B Andersson, D E Goodkin
Mar 24, 1999·Trends in Neurosciences·J J ArchelosH P Hartung
Sep 25, 1999·Journal of Neuroimmunology·M I GobbiniH F McFarland
Jan 5, 2000·The American Journal of Clinical Nutrition·M J JamesL G Cleland
Jun 14, 2000·Annals of Neurology·C LucchinettiH Lassmann
Jun 13, 2001·Neurology·UNKNOWN Secondary Progressive Efficacy Clinical Trial of Recombinant Interferon-Beta-1a in MS (SPECTRIMS) Study Group
Jun 27, 2001·Neurology·UNKNOWN PRISMS Study Group and the University of British Columbia MS/MRI Analysis Group.
Jul 4, 2001·The Journal of Nutrition·F ThiesP C Calder
Jul 4, 2001·Neuroreport·B K PuriD F Horrobin
Sep 11, 2001·Multiple Sclerosis : Clinical and Laboratory Research·M ChenS Dhib-Jalbut
Oct 10, 2001·Neurology·R ZivadinovM Zorzon
Jan 5, 2002·CNS Drugs·Karim MakhloufSamia J Khoury
Jan 16, 2002·Archives of Neurology·Rohit BakshiLawrence Jacobs
Jan 24, 2002·Neurology·P A CalabresiK A Whartenby
Feb 9, 2002·Annals of Neurology·Natalija PopovicIan D Duncan
Apr 17, 2002·Journal of Neurology·Oscar Fernández
May 4, 2002·Lancet·Luca DurelliUNKNOWN Independent Comparison of Interferon (INCOMIN) Trial Study Group
May 23, 2002·Brain : a Journal of Neurology·Veronika BrundulaV Wee Yong
Jun 22, 2002·Annals of the New York Academy of Sciences·Bin LiuJau-Shyong Hong
Jun 22, 2002·Brain : a Journal of Neurology·Claudia F LucchinettiHans Lassmann
Aug 7, 2002·Journal of the Neurological Sciences·M ChenS Dhib-Jalbut
Aug 20, 2002·Journal of Neurology, Neurosurgery, and Psychiatry·D T WadeD L W Davidson
Sep 11, 2002·Neurology·J A CohenUNKNOWN IMPACT Investigators
Sep 27, 2002·Annals of Neurology·Nancy L SicotteRhonda R Voskuhl
Nov 8, 2002·Nature·Sawsan YoussefScott S Zamvil
Citations
May 18, 2005·NeuroRx : the Journal of the American Society for Experimental NeuroTherapeutics·Jose C Masdeu, Rohit Bakshi
May 15, 2007·Current Opinion in Neurology·Fiona CostelloElliot Frohman
Jun 1, 2006·CNS Drugs·Noel G Carlson, John W Rose
Feb 1, 2007·Multiple Sclerosis : Clinical and Laboratory Research·B GranA M Rostami
Dec 21, 2006·Autoimmunity·Sergio E Baranzini
Aug 23, 2012·Neurological Research·Veronika TichaEva Havrdova
Mar 24, 2016·Therapeutic Advances in Neurological Disorders·Steven J GreenbergRohit Bakshi
Feb 25, 2009·Expert Opinion on Pharmacotherapy·Hans-Peter Hartung
Nov 1, 2008·Nature Reviews. Drug Discovery·Rocio S Lopez-Diego, Howard L Weiner
Aug 11, 2005·Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics·Vilmos AgostonSándor Pongor
Jun 11, 2020·Multiple Sclerosis and Related Disorders·H CheraghmakaniM Ghazaeian
Feb 16, 2010·Analytical Chemistry·Xiaotao DuanJun Qu